The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
JWH133 inhibits MPP+-induced inflammatory response and iron influx in astrocytes
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“studies have reported CB2 expression in certain neuronal populations, other glial cells, and by immune cells that infiltrate the CNS during inflammation”
From Novel floxed cannabinoid receptor 2 mouse line combines knockout capability with dual fluorescent reporters (2025) · cites this paper as Jia et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Introduction to the Endogenous Cannabinoid System
Lu, H.-C., & Mackie, K. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.07.028 · Cited by 1,234
Lee, H.-J., Suk, J.-E., Patrick, C., Bae, E.-J., Cho, J.-H., Rho, S., Hwang, D., Masliah, E., & Lee, S.-J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.081125 · Cited by 877
Does neuroinflammation fan the flame in neurodegenerative diseases?
Frank-Cannon, T. C., Alto, L. T., McAlpine, F. E., & Tansey, M. G. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-47 · Cited by 751
Morales, I., Guzmán-MartÃnez, L., Cerda-Troncoso, C., FarÃas, G. A., & Maccioni, R. B. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00112 · Cited by 490
Brain iron and ferritin in Parkinson’s and Alzheimer’s diseases
Jellinger, K., Paulus, W., Grundke-Iqbal, I., Riederer, P., & Youdim, M. B. H. (1990) · Journal of Neural Transmission - Parkinson's Disease and Dementia Section · doi:10.1007/bf02252926 · Cited by 445
Gunshin, H., Fujiwara, Y., Custodio, A. O., DiRenzo, C., Robine, S., & Andrews, N. C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24356 · Cited by 419
Cabral, G. A., & Griffin-Thomas, L. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409000957 · Cited by 408
The role of glial cells in Parkinsonʼs disease
Vila, M., Jackson-Lewis, V., Guégan, C., Chu Wu, D., Teismann, P., Choi, D.-K., Tieu, K., & Przedborski, S. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200108000-00009 · Cited by 326
Anandamide Inhibits Nuclear Factor-κB Activation through a Cannabinoid Receptor-Independent Pathway
Sancho, R., Calzado, M. A., Di Marzo, V., Appendino, G., & Muñoz, E. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.429 · Cited by 120
Theurl, I., Fritsche, G., Ludwiczek, S., Garimorth, K., Bellmann-Weiler, R., & Weiss, G. (2005) · BioMetals · doi:10.1007/s10534-005-3710-1 · Cited by 72
Research works printed but not linked: 35
- Lee, 2019, Parkinson’s disease-associated LRRK2- G2019S mutant acts through regulation of SERCA activity to control ER stress in astrocytes, Acta Neuropathol. Commun., 7, 68, 10.1186/s40478-019-0716-4 · DOI
- Stojkovska, 2015, Parkinson’s disease and enhanced inflammatory response, Experimental biology and medicine (Maywood, N.J.), Exp. Biol. Med., 240, 1387, 10.1177/1535370215576313 · DOI
- Liu, 2018, Orexin-a exerts neuroprotective effects via OX1R in parkinson’s disease, Front. Neurosci., 12, 835, 10.3389/fnins.2018.00835 · DOI
- Yasuda, 2008, The effects of MPTP on the activation of microglia/astrocytes and cytokine/chemokine levels in different mice strains, J. Neuroimmunol., 204, 43, 10.1016/j.jneuroim.2008.08.003 · DOI
- Forno, 1992, Astrocytes and Parkinson’s disease, Prog. Brain Res., 94, 429, 10.1016/S0079-6123(08)61770-7 · DOI · Paper page
- Kempuraj, 2017, Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration, Front. Cell. Neurosci., 11, 216, 10.3389/fncel.2017.00216 · DOI · Paper page
- Brough, 2015, Interleukin-1 as a pharmacological target in acute brain injury, Exp. Physiol., 100, 1488, 10.1113/EP085135 · DOI
- Cassano, 2017, Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target, Front. Neurosci., 11, 30, 10.3389/fnins.2017.00030 · DOI · Paper page
- Ma, 2019, Mechanisms of cannabinoid CB2 receptor- mediated reduction of dopamine neuronal excitability in mouse ventral tegmental area, EBioMedicine, 42, 225, 10.1016/j.ebiom.2019.03.040 · DOI
- Walter, 2004, Cannabinoids and neuroinflammation, Br. J. Pharmacol., 141, 775, 10.1038/sj.bjp.0705667 · DOI · Paper page
- Price, 2009, WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease, Eur. J. Neurosci., 29, 2177, 10.1111/j.1460-9568.2009.06764.x · DOI · Paper page
- Huffman, 1999, 3-(1’,1’-Dimethylbutyl)-1- deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor, Bioorg. Med. Chem., 7, 2905, 10.1016/S0968-0896(99)00219-9 · DOI · Paper page
- Martin-Moreno, 2012, Prolonged oral cannabinoid administration prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in Tg APP 2576 mice, J. Neuroinflammation, 9, 8, 10.1186/1742-2094-9-8 · DOI · Paper page
- Hirsch, 2009, Iron transport in Parkinson’s disease, Parkinsonism Relat. Disord., 15, S209, 10.1016/S1353-8020(09)70816-8 · DOI
- Seo, 2016, Regulation of divalent metal transporter-1 by serine phosphorylation, Biochem. J., 473, 4243, 10.1042/BCJ20160674 · DOI
- Wetli, 2006, Small-molecule screening identifies the selanazal drug ebselen as a potent inhibitor of DMT1-mediated iron uptake, Chem. Biol., 13, 965, 10.1016/j.chembiol.2006.08.005 · DOI
- Abad-Rodriguez, 2000, Purification and structure of neurostatin, an inhibitor of astrocyte division of mammalian brain, J. Neurochem., 74, 2547, 10.1046/j.1471-4159.2000.0742547.x · doi:10.1046/j.1471-4159.2000.0742547.x
- Tenopoulou, 2007, Does the calcein-AM method assay the total cellular’ labile iron pool’ or only a fraction of it?, Biochem. J., 403, 261, 10.1042/BJ20061840 · DOI
- Xu, 2019, L-type calcium channels are involved in iron-induced neurotoxicity in primary cultured ventral mesencephalon neurons of rats, Neuroscience Bulletin, 1
- Di Marzo, 2015, Endocannabinoid signalling and the deteriorating brain, Nat. Rev. Neurosci., 16, 30, 10.1038/nrn3876 · DOI · Paper page
- Chen, 2017, Brain cannabinoid receptor 2: expression, function and modulation, Acta Pharmacol. Sin., 38, 312, 10.1038/aps.2016.149 · DOI · Paper page
- Benito, 2008, Cannabinoid CB2 receptors in human brain inflammation, Br. J. Pharmacol., 153, 277, 10.1038/sj.bjp.0707505 · DOI · Paper page
- Facchinetti, 2003, Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide, Glia, 41, 161, 10.1002/glia.10177 · DOI · Paper page
- Ramirez, 2005, Prevention of Alzheimer’s disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation, The Journal of neuroscience: the official journal of the Society for Neuroscience, 25, 1904, 10.1523/JNEUROSCI.4540-04.2005 · DOI · Paper page
- Navarrete, 2018, Cannabinoid CB1 and CB2 receptors, and monoacylglycerol lipase gene expression alterations in the basal ganglia of patients with parkinson’s disease, Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics, 15, 459, 10.1007/s13311-018-0603-x · DOI
- Neal, 2018, Epigenetic regulation of astrocyte function in neuroinflammation and neurodegeneration, Biochimica et biophysica acta. Molecular basis of disease, 1864, 432, 10.1016/j.bbadis.2017.11.004 · DOI · Paper page
- Blandini, 2012, Animal models of Parkinson’s disease, FEBS J., 279, 1156, 10.1111/j.1742-4658.2012.08491.x · DOI · Paper page
- Kempuraj, 2018, Glia maturation factor and mast cell-dependent expression of inflammatory mediators and proteinase activated Receptor-2 in neuroinflammation, J. Alzheimers Dis., 66, 1117, 10.3233/JAD-180786 · DOI
- Howlett, 2002, The cannabinoid receptors, Prostaglandins Other Lipid Mediat., 68- 69, 619, 10.1016/S0090-6980(02)00060-6 · DOI · Paper page
- Saadat, 2015, Is the 1254T&C polymorphism in the DMT1 gene associated with Parkinson’s disease?, Neurosci. Lett., 594, 51, 10.1016/j.neulet.2015.03.054 · DOI
- He, 2011, DMT1 polymorphism and risk of Parkinson’s disease, Neurosci. Lett., 501, 128, 10.1016/j.neulet.2011.07.001 · DOI
- Wang, 2017, Isradipine attenuates MPTP-induced dopamine neuron degeneration by inhibiting up-regulation of L-type calcium channels and iron accumulation in the substantia nigra of mice, Oncotarget, 8, 47284, 10.18632/oncotarget.17618 · DOI
- Moos, 2007, Iron trafficking inside the brain, J. Neurochem., 103, 1730, 10.1111/j.1471-4159.2007.04976.x · DOI · Paper page
- Burkhart, 2016, Expression of Iron-Related Proteins at the Neurovascular Unit Supports Reduction and Reoxidation of Iron for Transport Through the Blood-Brain Barrier, Mol. Neurobiol., 53, 7237, 10.1007/s12035-015-9582-7 · DOI
- Kim, 2011, Influence of DMT1 and iron status on inflammatory responses in the lung, American journal of physiology, Lung cellular and molecular physiology, 300, L659, 10.1152/ajplung.00343.2010 · DOI
Cited by
Laloli, K. J., Rentsch, P., Stayte, S., & Vissel, B. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1682979 · Cited by 3
Metadata
- Authors
- Jia, Y., Deng, H., Qin, Q., & Ma, Z.
- ORCID
- Ma, ZeGang
- Venue
- Neuroscience Letters
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 720
- Pages
- 134779
- ISSN
- 0304-3940
- Cited by
- 18
- References
- 10
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- National Natural Science Foundation of China
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: JWH133 inhibits MPP+-induced inflammatory response and iron influx in astrocytes. https://app.cochat.ai/papers/10.1016/j.neulet.2020.134779
- The paper
- Jia, Y., Deng, H., Qin, Q., & Ma, Z. (2020). JWH133 inhibits MPP+-induced inflammatory response and iron influx in astrocytes. Neuroscience Letters. https://doi.org/10.1016/j.neulet.2020.134779
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.